Bruker Corporation (NasdaqGS:BRKR) entered into an agreement to acquire ELITech Group SAS from Tecfin S.À R.L. for approximately ?870 million on February 27, 2024. Bruker expects to fund the acquisition using cash on hand and established debt financing. Upon closing, ELITech is expected to be a stand-alone business within Bruker?s Microbiology and Infection Diagnostics division, as a part of the Bruker CALID Group.

The transaction does not include the ELITech Group's ELITech clinical chemistry business, which will be carved out. The transaction is subject to regulatory approvals, the carve-out of the clinical chemistry business, and other customary closing conditions. Bruker expects to close the transaction in the second quarter of 2024.

As on April 26, 2024, All regulatory clearances for this acquisition have now been received, and closing of the acquisition is expected during Q2 2024, subject to remaining closing conditions. Hendrik Hirsch, Jacob Siebert, Dirk Baukholt, Berrit Roth-Mingram, Roland Wiring, Thomas Hirse, Michael Bauer, Stefan Lehr, Kai Neuhaus, Moritz Pottek, Denis Schlimpert, Thomas de la Motte, Markus Pfaff, André Frischemeier, Hatice Aykel, André Lippert, Boris Alles from CMS Hasche Sigle Partnerschaft von Rechtsanwälten und Steuerberatern mbB and Benoît Gomel,Caroline Froger-Michon, Dylan Allali, Sophie Yin, Claire Vannini, Eleni Moraïtou, Ariane Rolin, Jean-Baptiste, Alexandre Chazot, Thierry Granier, Renaud Grob, Alexandre Chazot, Thierry Granier, Renaud Grob, Olivier Kuhn, Cécile Rebiffé, Mylène Garrouste, Kawthar Ben Khelil from CMS Francis Lefebvre Avocats acted as legal advisors to Bruker Corporation (NasdaqGS:BRKR). Massimo Trentino, Maria Letizia Patania, Giulio Poggioli from CMS Legal Services EEIG and Gérard Maitrejean, Miruna Poenaru from CMS Luxembourg SARL acted as legal advisors to Bruker Corporation (NasdaqGS:BRKR).

Jack Letson from CMS Cameron McKenna Nabarro Olswang LLP and Pieter van Duijvenvoorde, Robert Jong, Nigel Henssen, Fleur van Assendelft de Coningh, Edmon Oude Elferink, Marijke van der Vossen from CMS Derks Star Busmann N.V. acted as legal advisors to Bruker Corporation (NasdaqGS:BRKR). Radivoje Petrikic, Mila Drljevic from CMS Reich-Rohrwig Hasche Sigle d.o.o. Dieter Zandler, Vanessa Horaceck from CMS Reich-Rohrwig Hainz Rechtsanwälte GmbH acted as legal advisors to Bruker Corporation (NasdaqGS:BRKR). Maria Orlyk, Diana Valyeyeva from CMS kyiv and Döne Yalçin, Arcan Kemahli, Sabahattin Öztemiz, Taner Elmas from CMS Danismanlik Hizmetleri Avukatlik Ortakligi acted as legal advisors to Bruker Corporation (NasdaqGS:BRKR).